Announcement under Regulation 30 (LODR)-Acquisition 15 Oct - Aeroflex Neu approved ₹16.00 crore acquisition of 31.43% more Stilonn shares, taking stake to 51.01%.
Source: Bse
Industrials stocks · Small cap · NSE
Sah Polymers Limited manufactures and exports Flexible Intermediate Bulk Containers (FIBCs), Polypropylene Woven Bags, and BOPP Laminated Bags. With over 25 years in business, it serves agriculture, petrochemicals, metals, minerals, cement, textiles, and fertilizers, and is a Del Credere Associate of IOCL.
SMA20 -6.6% / mo · MACD +
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is weak.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue -4.9% · PAT -90.1% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev -5% YoY · PAT -90% YoY · margin expansion
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹28.2 Cr | -4.9% | -17.1% |
| EBITDA | ₹1 Cr | +35.2% | +1500.0% |
| Operating margin | 3.4% | +101 bps | +322 bps |
| PAT | ₹0.1 Cr | -90.1% | NDF |
| PAT margin | 0.3% | -245 bps | +283 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 49. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 13 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Q4 & FY25 results show revenue growth but significant margin contraction. Q4 Total Income rose 5.86% YoY to `34.74 Cr, but EBITDA fell 35.05% and PAT was negative `(0.33) Cr. FY25 Total Income grew 17.82% YoY to `131.39 Cr, while EBITDA declined 11.15% and PAT dropped 75.11%.
While Sah Polymers is strategically expanding into higher-margin food and pharma packaging with BRC certification and targeting 20-25% CAGR, current financial performance shows severe margin pressure. The Q4 PAT loss and substantial FY25 PAT decline raise concerns about profitability and execution of growth plans.
Latest issuer-disclosed distribution across 2 reported categories.
Strategic entry into food and pharma grade bulk packaging market with BRC certification.
Plan to grow exports from 30+ countries to 60+ countries in the next 5 years.
Further expansion into adjacent product categories like Technical Textiles.
Actively seeking/evaluating companies for strategic investments to expand footprint and business.
Commissioned the 2nd manufacturing facility in 2023, doubling total production capacity to 7,920 TPA.
Current total consolidated capacity is 9,120 MTPA (Sah 7,920 MTPA + Fibcorp 1,200 MTPA).
Plan to increase production capacity from 9,120 MTPA on a need basis, including utilizing contract manufacturing.
BRC Certification enables supply to the lucrative Food, Pharma & Beverage Industry.
Food and Pharma packaging solutions have potentially better margin profiles.
Objective to capitalize on growing global demand with cutting-edge packaging solutions.
Significant decline in EBITDA and PAT margins in Q4 and FY25, raising concerns about cost management or pricing power.
Achieving projected 20-25% CAGR and improved margins from food/pharma packaging requires successful market penetration and operational efficiency.
Decision to withdraw Fibcorp Polyweave amalgamation application could signal integration challenges or strategic shifts.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The document provides both Q4 and FY25 results with YoY comparisons, which are crucial for assessing both short-term momentum and annual performance trends in a business that may have seasonal elements or project-based revenue recognition.
Q4 FY25 3.00% (Q4 FY24 4.88%); FY25 4.73% (FY24 6.28%).
Q4 FY25 (0.96%) (Q4 FY24 0.39%); FY25 0.18% (FY24 0.83%).
Increased to `51.58 Cr as of March 31, 2025, from `48.01 Cr in March 2024.
Decreased to `21.35 Cr as of March 31, 2025, from `22.03 Cr in March 2024.
Strategically entering the food and pharma grade bulk packaging market with a meticulous focus on quality, compliance, and sustainability.
Projected 20 to 25% CAGR growth for next 5 years.
Improved EBITDA and PAT driven by enhanced manufacturing efficiency and Food and Pharma packaging solutions.
Actively seeking/evaluating companies, in India and abroad, to make strategic investments and expand the footprint.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| EBITDA Margin | Q4 FY25 3.00%, FY25 4.73% | Sustained improvement in margins, especially from new food/pharma segments. |
| PAT | Q4 FY25 `(0.33) Cr, FY25 `0.23 Cr | Return to consistent positive PAT and growth in absolute profit. |
| Export Market Reach | 30+ countries | Expansion to new countries and increased export revenue contribution. |
| Capacity Utilization | Total consolidated capacity 9,120 MTPA | Disclosure of utilization rates and actual capacity additions beyond current levels. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 38th percentile of the scored universe and 35th percentile within Industrials. Main check: financial discipline is weak at 20/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Industrials: 35th pctile, median 68 · Small: 43rd pctile, median 66
21 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse